1. Disclaimer: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. 2. This acquisition is issued as a Request for Quote (RFQ). 3. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-04. 4. For purposes of this acquisition, the associated NAICS code is 811310. The small business size standard is $12.5 million. This action is being solicited as a small business set aside. 5. Line-Item Structure: The following is a list of line-item number(s) and items, quantities and units of measure, (including option(s), if applicable) and should be reflected in the Offeror's quote/proposal: Line Item Description Quantity Period of Performance Price 1 Schedule 1 Monthly Inspection 6 Six months from award $ 2 Schedule 2 Bi-Monthly 3 Six months from award $ 3 Schedule 3 Once 1 Six months from award $ TOTAL PRICE $$$ 6. Specifications/Requirement: See attached SOW document. 7. Maintenance service is required six months from award. Maintenance service shall be performed at 109 Holton Street Winchester MA 01890. 8. The provision at 52.212-1, Instructions to Offerors - Commercial DEVIATION 2018-O0018, applies to this acquisition. The following addenda have been attached to this provision: In addition to the requirements set for the in FAR 52.212-1, all offers responding to this solicitation must provide their business size in relation to the NAICS code contained in this solicitation and shall identify any socioeconomic categories to which they belong. 9. Evaluation Criteria - FDA will evaluate all quotes received in response to this solicitation by using the lowest- price technically acceptable (LPTA) methodology. Quotes must meet all the salient functional characteristics and requirements of this solicitation in order to be considered technically acceptable. Quotes providing an equivalent solution will not be considered further if the requisite functionality/compatibility explanation is not provided. FDA will issue the award to the Quoter whose proposed solution meets all technical requirements, including the Terms and Conditions identified within the solicitation, and whose overall price is lowest. Quoter's are advised that additional terms and conditions submitted with their quotation that are in conflict of the terms and conditions of this solicitation may be deemed technically unacceptable and may not be considered for award. 10. Offerors shall include a completed copy of the provision at FAR 52.212-3 (with its Alternate I), Offeror Representations with its offer. 11. The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to this clause-NONE. 12. The clause 52.212-5 Contract Terms and Conditions Required To Implement Statutes or Executive Orders--Commercial Products and Commercial Services (Jun 2023) applies to this acquisition. The following additional FAR clauses cited in this clause are applicable: 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards (Jun 2020) 52.209-6 Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (Nov 2021) 52.219-4 Notice of Price Evaluation Preference for HUBZone Small Business Concerns (Oct 2022) 52.219-28 Post Award Small Business Program Rerepresentation (Mar 023) 52.222-3 Convict Labor (Jun 2003) 52.222-19 Child Labor-Cooperation with Authorities and Remedies (Dec 2022) 52.222-21 Prohibition of Segregated Facilities (Apr 2015). 52.222-26 Equal Opportunity (Sep 2016) 52.222-36 Equal Opportunity for Workers with Disabilities (Jun 2020) 52.222-50 Combating Trafficking in Persons (Nov 2021) 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (Jun 2020) 52.225-13 Restrictions on Certain Foreign Purchases (Feb 2021) 52.232-33 Payment by Electronic Funds Transfer-System for Award Management (Oct 2018) 13. The following additional contract requirement(s) or terms and conditions apply: 52.204-7 System for Award Management (Oct 2018). 52.204-16 Commercial and Government Entity Code Reporting (Aug 2020). 52.204-22 Alternative Line Item Proposal (Jan 2017). 52.204-13 System for Award Management Maintenance (Oct 2018). 52.204-18 Commercial and Government Entity Code Maintenance (Aug 2020). 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014). 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015) 352.232-71 Electronic submission of payment requests 352.239-73 Electronic and Information Technology Accessibility Notice (Dec 2015) 14. This acquisition is rated under the Defense Priorities and Allocations System (DPAS) as N/A. 15. Date, Time, and Place offers are due: Quote is due electronically via email to Natalie.Brown@fda.hhs.gov for this solicitation no later than 28 July 2023, 11:59pm. Eastern Time. Late submissions may not be evaluated. The subject line shall read: 75F401-23-Q-1266874 Laboratory Reverse Osmosis (RO) Water Purification System Maintenance 16. Name and Telephone Number of the Individual to Contact for Information Regarding the Solicitation: Natalie Brown, 301-837-7670